Figure 5

Comparison of data between patients with and without l-carnitine supplementation within the observational period. (a) Relative changes in the psoas muscle mass index (PMI) at SVR48 in patients with and without l-carnitine supplementation. (b) Changes in serum total and free carnitine levels between baseline and at SVR48 in patients with and without l-carnitine initiation. (c) Correlations between psoas muscle mass index (PMI) changes/month (ΔPMI/month) and changes in serum total/free creatinine in patients without l-carnitine initiation. PMI psoas muscle mass index. Data were analyzed using Spearman’s rank correlation.